Department of Pharmacy and Pharmaceutical Technology, Biopharmaceuticals and Pharmacokinetics Unit, Faculty of Pharmacy, University of Barcelona, Barcelona, Spain. xavier.garcia @ ipsen.com
Pharmacology. 2010;86(4):216-23. doi: 10.1159/000319747. Epub 2010 Sep 9.
Tricyclic antidepressants (TCA) have potent local anesthetic properties and may produce a long-lasting pain blockade that could be of interest in relieving chronic pain states such as neuropathic pain, but there are only few data comparing their dose-response curves of analgesic activity under the same experimental conditions. This study examines the time course of pain-relieving properties of 7 TCA in heat-induced paw withdrawal after subcutaneous administration. Mixed inhibitors of norepinephrine and serotonin uptake (amitriptyline, nortriptyline, imipramine, desipramine, doxepin) and selective inhibitors of serotonin uptake (fluoxetine and fluvoxamine) were assayed. The TCA with the longest analgesic activity were selected to test its antiallodynic effect in the neuropathic pain model of chronic sciatic nerve constriction injury. Bupivacaine was used as a reference drug in both experiments. A dose versus time of maximal analgesic effect curve was constructed for each drug. The longest analgesic effect was obtained for doxepin and imipramine. Although low doses of amitriptyline showed the same activity than doxepin, higher doses failed to reach the same effect. Selective inhibitors of serotonin showed no action at all doses tested. In the chronic sciatic nerve constriction injury model, doxepin and, to a smaller degree, amitriptyline and imipramine protected from allodynia; bupivacaine was ineffective. The antiallodynic effect always lasted less long than the analgesic effect. These observations provide support for the potential use of TCA as durable analgesics. Doxepin overall showed the most outstanding results in pain relief.
三环类抗抑郁药(TCA)具有很强的局部麻醉作用,并可能产生持久的镇痛作用,这可能对缓解慢性疼痛状态如神经病理性疼痛有兴趣,但只有少数数据比较它们在相同实验条件下的镇痛活性剂量-反应曲线。本研究考察了 7 种 TCA 在皮下给予后热诱导的足底撤回中的镇痛作用的时间过程。测定了去甲肾上腺素和 5-羟色胺摄取的混合抑制剂(阿米替林、去甲替林、丙咪嗪、地昔帕明、多塞平)和 5-羟色胺摄取的选择性抑制剂(氟西汀和氟伏沙明)。选择镇痛活性最长的 TCA 来测试其在慢性坐骨神经缩窄损伤神经病理性疼痛模型中的抗痛觉过敏作用。布比卡因在这两个实验中均被用作参考药物。为每种药物构建了剂量-时间最大镇痛效应曲线。多塞平和丙咪嗪的镇痛作用最长。虽然低剂量的阿米替林表现出与多塞平相同的活性,但更高剂量未能达到相同的效果。选择性 5-羟色胺抑制剂在所有测试剂量下均无作用。在慢性坐骨神经缩窄损伤模型中,多塞平、在较小程度上还有阿米替林和丙咪嗪可预防痛觉过敏;布比卡因无效。抗痛觉过敏作用总是持续时间短于镇痛作用。这些观察结果为 TCA 作为持久的镇痛剂的潜在用途提供了支持。多塞平在缓解疼痛方面总体上表现出最突出的效果。